Prediction: Eli Lilly Will Be Worth $2 Trillion by 2031
And it will likely be the first company in the sector to get there.
Overview
Eli Lilly (NYSE: LLY) made history last year when it became the first healthcare stock to hit a $1 trillion market cap. It hasn't performed that well since, due to a combination of factors, including questions about its valuation. However, the company is riding a powerful tailwind that could allow it to become a $2 trillion corporation in five years, nearly doubling from its current levels. Here is why the stock is a buy.
Image source: The Motley Fool.
Over the past three years, Eli Lilly's revenue growth has been more comparable to that of a smaller tech corporation than to that of a major pharmaceutical giant.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.